Anti-PCSK9 monoclonal antibody (Biocad)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-PCSK9 monoclonal antibody (Biocad)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors

TargetsProprotein convertase subtilisin kexin type 9

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBIOCAD JSC

China Registration ClassN/A

Active CompaniesBIOCAD JSC

Inactive CompaniesN/A

Active IndicationsCardiovascular Diseases

Inactive IndicationsN/A

ATC CodeN/A